Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.64371 | 27 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.6006 | 26 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.60236 | 26 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.53701 | 25 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.53718 | 25 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.68887 | 27 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.6442 | 26 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.5722 | 25 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.55964 | 25 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.58728 | 26 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.5868 | 26 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.5735 | 26 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.58971 | 26 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.59505 | 26 |